SCHEMBL20354566

SCHEMBL20354566

CC(=O)NC1(C)CCN(c2ccc(N)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 6/20 0.54
CASP6 P55212 1/20 0.54
MAPT P10636 10/20 0.45
ALDH1A1 P00352 8/20 0.45
GAA P10253 6/20 0.45
KMT2A Q03164 5/20 0.45
KDM4E B2RXH2 4/20 0.45
ADRA2C P18825 1/20 0.45
PTK2B Q14289 1/20 0.45
ESR2 Q92731 1/20 0.45
MEN1 O00255 4/20 0.43
USP2 O75604 3/20 0.42
HTT P42858 2/20 0.42
HSD17B10 Q99714 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.42
THRB P10828 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22055754 0.84 USP2 (0.56) MAPTALDH1A1KMT2AKDM4EMEN1
SCHEMBL21526470 0.81 SIRT6 (0.54) MAPTALDH1A1KMT2AMEN1TP53
SCHEMBL20354567 0.81 GFER (0.50) GFERCASP6MAPTALDH1A1GAA
SCHEMBL29224968 0.81 GFER (0.43) GFERCASP6MAPTALDH1A1GAA
SCHEMBL29224997 0.76 ITGB3 (0.43) GFERMAPTALDH1A1GAAKMT2A
SCHEMBL22055753 0.75 FFAR4 (0.51) MAPTALDH1A1GAAKMT2AMEN1
SCHEMBL19701965 0.75 NOTUM (0.49) GFERMAPTALDH1A1KMT2AMEN1
SCHEMBL13724583 0.75 MAPT (0.55) GFERCASP6MAPTALDH1A1GAA
SCHEMBL18937140 0.75 MAPT (0.59) GFERCASP6MAPTALDH1A1GAA
SCHEMBL23126615 0.74 CASP6 (0.73) GFERCASP6ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3564232-B1 BMP-SIGNAL-INHIBITING COMPOUND RIKEN (JP) 2022-01-26 EP disclosed
EP-3564232-B1 BMP-SIGNAL-INHIBITING COMPOUND RIKEN (JP) 2022-01-26 EP disclosed
US-10954216-B2 BMP-signal-inhibiting compound RIKEN (JP) 2021-03-23 US disclosed
US-10954216-B2 BMP-signal-inhibiting compound RIKEN (JP) 2021-03-23 US disclosed
US-20190337926-A1 BMP-SIGNAL-INHIBITING COMPOUND RIKEN (JP) 2019-11-07 US disclosed
US-20190337926-A1 BMP-SIGNAL-INHIBITING COMPOUND RIKEN (JP) 2019-11-07 US disclosed
EP-3564232-A1 BMP-SIGNAL-INHIBITING COMPOUND Riken (JP) 2019-11-06 EP disclosed
WO-2018124001-A1 BMP-SIGNAL-INHIBITING COMPOUND 国立研究開発法人理化学研究所 2018-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10954216-B2 BMP-signal-inhibiting compound BMP1, BMP2, BMP4 GFER 4662/4885CASP6 555/4885MAPT 4782/4885
US-20190337926-A1 BMP-SIGNAL-INHIBITING COMPOUND BMP1, BMP2, BMPR2 GFER 4743/4885CASP6 595/4885MAPT 4243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.